Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens

Bacterial pathogens cause a number of lethal diseases. Opportunistic bacterial pathogens grouped into ESKAPE pathogens that are linked to the high degree of morbidity, mortality and increased costs as described by Infectious Disease Society of America. Acinetobacter baumannii is one of the ESKAPE pa...

Full description

Bibliographic Details
Published in:	Frontiers in Microbiology
Main Authors:	Vishvanath eTiwari, Ranita eRoy, Monalisa eTiwari
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-06-01
Subjects:	Acinetobacter baumannii Herbal Medicine Antibacterial activity MIC Carbapenem resistance
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.00618/full

Similar Items

Quantitative Proteomics to study Carbapenem Resistance in Acinetobacter baumannii
by: Vishvanath eTiwari, et al.
Published: (2014-09-01)

Evaluation of synergistic effect of tazobactam with meropenem and ciprofloxacin against multi-drug resistant Acinetobacter baumannii isolated from burn patients in Tehran
by: Valadan Tahbaz, Sahel, et al.
Published: (2019-08-01)

Polyvinylpyrrolidone-Capped Silver Nanoparticle Inhibits Infection of Carbapenem-Resistant Strain of Acinetobacter baumannii in the Human Pulmonary Epithelial Cell
by: Vishvanath Tiwari, et al.
Published: (2017-08-01)

The Antibacterial Activity Evaluation of the Nanoparticles of Silver on Acinetobacter Baumannii
by: Seyedeh Nasim Karimipour, et al.
Published: (2016-08-01)

Pathogenicity factors of Acinetobacter baumannii
by: E. N. Gudueva, et al.
Published: (2023-03-01)

Acinetobacter baumannii Isolated from Lebanese Patients: Phenotypes and Genotypes of Resistance, Clonality, and Determinants of Pathogenicity
by: Elias Dahdouh, et al.
Published: (2016-11-01)

In-silico study of Lebanese herbal compounds against carbapenem-resistant Acinetobacter baumannii proteins
by: Israa Assaf, et al.
Published: (2023-01-01)

Phenotypic and molecular characterisations of carbapenem-resistant Acinetobacter baumannii strains isolated in Madagascar
by: Pierrette Landrie Simo Tchuinte, et al.
Published: (2019-02-01)

Carbapenem Resistant Acinetobacter baumannii: Current Status of Problem in a Tertiary Care Hospital, Jaipur
by: Ekadashi Rajni, et al.
Published: (2023-06-01)

The H-NS Regulator Plays a Role in the Stress Induced by Carbapenemase Expression in Acinetobacter baumannii
by: Fanny Huang, et al.
Published: (2020-08-01)

Detection of Clonal Relationship Between Carbapenem-resistant Acinetobacter baumannii Isolates in an University Hospital
by: Yasemin KIRIK, et al.
Published: (2021-12-01)

Epidemiological features of healthcare-associated Acinetobacter baumannii infections in Taiwan during 2008 − 2019
by: Chi-Jeng Hsieh, et al.
Published: (2023-01-01)

Genotyping Analysis of Nosocomial Acinetobacter baumannii Strains
by: Solomenniy A.P., et al.
Published: (2015-11-01)

Prevalence of carbapenem resistance genes in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii from meat samples
by: Maryam Rezaeian, et al.
Published: (2025-01-01)

Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe
by: Ivana Goic-Barisic, et al.
Published: (2023-06-01)

Antibacterial activities of bacteria associated with marine sponges of Axinella sp. on Carbapenem-Resistant Acinetobacter Baumannii (CRAB)
by: Muhammad Evy Prastiyanto, et al.
Published: (2022-02-01)

Risk factors for hospital infections caused by carbapanem-resistant Acinetobacter baumannii
by: Zorana M Djordjevic, et al.
Published: (2016-10-01)

Effectiveness of Colistin in carbapenem resistant Acinetobacter baumannii – A systematic review
by: Feroz Ahmed, et al.
Published: (2023-09-01)

Comparative Analysis of Clinical Characteristics and Antimicrobial Resistance Between <i>Acinetobacter baumannii</i> and Other <i>Acinetobacter</i> Species
by: Si-Ho Kim, et al.
Published: (2025-01-01)

Carbapenem-resistant Acinetobacter baumannii carrier detection: a simple and efficient protocol
by: Jonathan Lellouche, et al.
Published: (2024-04-01)

Indications of carbapenem resistance evolution through heteroresistance as an intermediate stage in Acinetobacter baumannii after carbapenem administration Indicações da evolução da resistência ao carbapenem através da heteroresistência como estágio intermediário no Acinetobacter baumannii após administração de carbapenem
by: Silvana Vargas Superti, et al.
Published: (2009-04-01)

Rapid detection of Acinetobacter baumannii and molecular epidemiology of carbapenem-resistant A.baumannii in two comprehensive hospitals of Beijing, China
by: Puyuan eLi, et al.
Published: (2015-09-01)

Pharmacokinetic/pharmacodynamic (PK/PD) simulation for dosage optimization of colistin and sitafloxacin, alone and in combination, against carbapenem-, multidrug-, and colistin-resistant Acinetobacter baumannii
by: Vipavee Rodjun, et al.
Published: (2023-11-01)

Hemorrhagic bronchitis caused by carbapenem-resistant Acinetobacter baumannii infection: A case report
by: Zifang Li, et al.
Published: (2024-01-01)

First report of SPM metallo-β-lactamases producing Acinetobacter baumannii isolates in Morocco
by: Abdelhamid Massik, et al.
Published: (2022-08-01)

Green synthesis of silver nanoparticles using curcumin: A comparative study of antimicrobial and antibiofilm effects on Acinetobacter baumannii against chemical conventional methods
by: Marwa A. Abdelwahab, et al.
Published: (2024-01-01)

Sub-MIC antibiotics increased the fitness cost of CRISPR-Cas in Acinetobacter baumannii
by: Ting Yu, et al.
Published: (2024-07-01)

Extensively drug-resistant Acinetobacter baumannii isolated in a university hospital: Role of inter-hospital transmission
by: Gonzalo Rivera, et al.
Published: (2016-01-01)

Antimicrobial Susceptibility Pattern of Acinetobacter Baumannii and Rate of Carbapenem Resistance at a Tertiary Care Hospital in Karachi
by: Shomaila Malik, et al.
Published: (2017-06-01)

Unusual community-associated carbapenem-resistant Acinetobacter baumannii infection, Pennsylvania, USA
by: Mohamed H. Yassin, et al.
Published: (2020-01-01)

Clinical burden of Acinetobacter baumannii, including carbapenem-resistant A. baumannii, in hospitalized adult patients in the USA between 2018 and 2022
by: Thomas P. Lodise, et al.
Published: (2025-04-01)

Exploring the clinical outcomes and molecular characteristics of Acinetobacter baumannii bloodstream infections: a study of sequence types, capsular types, and drug resistance in China
by: Jiao Chen, et al.
Published: (2025-02-01)

Virulence factors are preserved within carbapenem-resistant Acinetobacter baumannii clades
by: Mor N. Lurie-Weinberger, et al.
Published: (2025-12-01)

Genomic epidemiology of Acinetobacter baumannii goes global
by: Santiago Castillo-Ramírez
Published: (2023-12-01)

Risk Factors for Development and Mortality of Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
by: Li L, et al.
Published: (2024-12-01)

Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii Infection
by: Du N, et al.
Published: (2024-08-01)

Transcriptomic investigations of polymyxins and colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii
by: Xingchen Bian, et al.
Published: (2024-12-01)

Clinical and molecular features of NDM-producing Acinetobacter baumannii in a multicenter study in Israel
by: Amos Adler, et al.
Published: (2023-06-01)

Rapid identification of capsulated Acinetobacter baumannii using a density-dependent gradient test
by: Hadas Kon, et al.
Published: (2020-09-01)

Evaluation of Colistin Susceptibility in Carbapenem‐Resistant Acinetobacter baumannii Isolates Using Broth Microdilution, MICRONAUT‐MIC‐Strip, and VITEK MS
by: Fatih Mehmet Akıllı, et al.
Published: (2025-08-01)